组合疗法延迟了 Staphylococcus aureus 适应性实验室进化后的抗菌耐药性
Maiken Engelbrecht Petersen1, Amanda Batoul Khamas1, Lars Jørgen Østergaard2
1Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, Denmark.
Antimicrobial agents and chemotherapy
|March 14, 2025
概括
向抗持续性细胞的抗持续性药物,如米托米辛C,可以防止抗生素耐药性. 将抗生素与米托米辛C结合使用,延迟了耐药性,特别是抑制了Staphylococcus aureus的耐力.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗生素耐药性是全球主要的健康威胁,长期治疗和持续细胞的出现加剧了这种威胁.
- 持久性细胞,耐受抗生素,可以隐藏抵抗机制,并导致慢性感染的治疗失败.
- 用新型抗持久性药物向持久性细胞是一个有希望的策略,以防止抗生素耐药性的发展.
研究的目的:
- 研究结合抗生素与抗持久性药物mitomycin C在预防抗生素耐药性的有效性.
- 分析与抗生素压力下的适应性实验室进化相关的遗传和表型变化.
- 探索米托米辛C在抑制黄金葡萄球菌 (Staphylococcus aureus) 耐药性的潜力.
主要方法:
- 在42天的时间里,使用各种抗生素单独或与菌素C一起,对*黄金葡萄球菌*的适应性实验室进化.
- 每天对抗生素敏感性的监测和表型变化 (生长,生物膜形成) 的评估.
- 全基因组测序以确定与耐药性和表型转变相关的突变.
主要成果:
- 利芬辛耐药性迅速出现,而西普罗夫洛克萨辛和达普托米辛耐药性需要大约3周.
- 单独的万科米和米托米C对敏感性的影响很小.
- 组合疗法延迟了耐药性,而利法素-米托米辛C组合在整个实验中独特地保持了利法素敏感性.
- 暴露于米托米辛C导致了DNA修复和阿佐雷达酶系统中的新奇突变.
结论:
- 组合疗法,特别是与抗持久性药物,如米托米辛C,可以延迟抗生素耐药性.
- 米托米辛C在预防对特定抗生素 (如利芬皮辛) 的耐药性方面表现出潜力.
- 需要进一步的研究来评估抗持久性药物的临床适用性,以对抗各种感染中的耐药性.
相关概念视频
Antibiotic Selection
52.1K
Overview
52.1K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Genomic DNA in Prokaryotes
43.3K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.3K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


